Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New anal plug aims to stop leaks and boost confidence

NCT ID NCT04657588

First seen Jan 11, 2026 · Last updated Jun 23, 2026 · Updated 22 times

Summary

This study tested a new, liquid-filled anal insert called Navina for people with faecal incontinence. The device is designed to be comfortable and adapt to the body to prevent leakage. Researchers compared it to usual care in 73 adults aged 16-90. The goal was to see if the device improves quality of life and is cost-effective.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FAECAL INCONTINENCE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Maastricht University Medical Centre

    Maastricht, Limburg, 6229HX, Netherlands

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Navina anal insert (a liquid-filled, single-use rectal device)

What this could lead to

If it works, this device could offer a comfortable, non-surgical option to help people with faecal incontinence control leakage and improve daily life.

What could go wrong

This was a small, completed trial with 73 participants. The device may not work for everyone, and some people might find it uncomfortable or difficult to use.

Conditions

The condition(s) this trial relates to.

Encopresis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.